Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Blood (2007) 110 (11): 1490.

https://doi.org/10.1182/blood.V110.11.1490.1490

Published: 2007

Journal Articles

Serum Free Light Chain Ratio (FLCR) at Diagnosis Constitute a Powerful Prognostic Factor of Survival in Multiple Myeloma (MM).

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Nicoletta Kafasi, MD, Sotirios Sachanas, MD, Tatiana Tzenou, MD, Argiroula Papadogiannis, MD, Zacharoula Galanis, MD, Christina Kalpadakis, MD, Maria Dimou, MD, Elias Kyriakou, MD, Maria K. Angelopoulou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 3522.

https://doi.org/10.1182/blood.V108.11.3522.3522

Published: 2006

Journal Articles

B-Chronic Lymphoproliferative Disorders (BCLD) Presenting with Splenomegaly: Differential Diagnosis and Outcome.

Maria K. Angelopoulou, MD, Maria Papakonstantinou, MD, Flora N. Kontopidou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Theodoros P. Vassilakopoulos, MD, Christina Kalpadakis, MD, Styliani Kokoris, MD, Evangelia M. Dimitriadou, MD, Zacharoula Galani, MD, Sotirios Sachanas, MD, Padelis Tsirkinidis, MD, Marie-Christine Kyrtsonis, MD, Penelope Korkolopoulou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 4655.

https://doi.org/10.1182/blood.V108.11.4655.4655

Published: 2006

Journal Articles

Long Term Follow up of Hairy Cell Leukemia (HCL) Patients (PTS) Treated with Interferon-Alpha (IFN-α). The Importance of Maintenance.

Sotirios Sachanas, Maria K. Angelopoulou, Konstantinos Anargyrou, Styliani I. Kokoris, Theodoros P. Vassilakopoulos, Zacharoula I. Galani, Evangelia M. Dimitriadou, Marina P. Siakantaris, Maria N. Dimopoulou, Flora N. Kontopidou, Marie-Christine Kyrtsonis, Eleni Plata, Panayiotis Tsaftaridis, Panayiotis Panayiotidis, Gerassimos A. Pangalis

Blood (2006) 108 (11): 4718.

https://doi.org/10.1182/blood.V108.11.4718.4718

Published: 2006

Journal Articles

Efficacy of Rituximab in Hairy Cell Leukemia.

Styliani I. Kokoris, Maria K. Angelopoulou, Zacharoula I. Galani, Konstantinos Anargyrou, Sotirios Sachanas, Theodoros P. Vassilakopoulos, Marina P. Siakantaris, Flora N. Kontopidou, Evangelia M. Dimitriadou, Maria N. Dimopoulou, Panayiotis Tsaftaridis, Eleni Plata, Christina Kalpadakis, Marie-Christine Kyrtsonis, Panayiotis Panayiotidis, Gerassimos A. Pangalis

Blood (2006) 108 (11): 4719.

https://doi.org/10.1182/blood.V108.11.4719.4719

Published: 2006

Journal Articles

Rituximab-CHOP (R-CHOP) and Radiotherapy (RT) for Primary Mediastinal Large B-Cell Lymphoma (PMLBCL).

Blood (2006) 108 (11): 2745.

https://doi.org/10.1182/blood.V108.11.2745.2745

Published: 2006

Journal Articles

Retrospective Analysis of 41 Consecutive Patients with Non Gastrointestinal (GI) Extranodal Marginal Zone B-Cell Lymphoma (EMZL): Correlation of Clinical Characteristics and Outcome with Disease Localization.

Christina Kalpadakis, MD, Marina P. Siakantaris, MD, Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Tatiana Tzenou, MD, Maria N. Dimopoulou, MD, Evangelia M. Dimitriadou, MD, Styliani I. Kokoris, MD, Maria K. Angelopoulou, MD, Fotios Mitropoulos, MD, Penelope Korkolopoulou, MD, Gerassimos A. Pangalis, MD.

Blood (2005) 106 (11): 4785.

https://doi.org/10.1182/blood.V106.11.4785.4785

Published: 2005

Journal Articles

Serum Levels of OPG and MIP-1α in Untreated Multiple Myeloma Patients. Correlations with Staging, Survival and Bone Disease.

Argyro Papadogiannis, MD, Marie-Cristine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Tatiana Tzenou, MD, Antonios G. Antoniadis, MD, Christina Kalpadakis, MD, Sotirios Sachanas, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria K. Angelopoulou, MD, Eleni Plata, MD, Panagiotis Tsaftaridis, MD, Gerassimos Pangalis, MD

Blood (2005) 106 (11): 5074.

https://doi.org/10.1182/blood.V106.11.5074.5074

Published: 2005

Journal Articles

Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.

Marie-Christine Kyrtsonis, MD, Sotirios Sachanas, MD, Theodoros P. Vassilakopoulos, MD, Nikoletta Kafassi, MD, Tatiana Tzenou, MD, Argyro Papadogiannis, MD, Christina Kalpadakis, MD, Antonios G. Antoniadis, MD, Maria N. Dimopoulou, MD, Maria K. Angelopoulou, MD, Marina P. Siakantaris, MD, Evangelia M. Dimitriadou, MD, Styliani I. Kokoris, MD, Eleni Plata, MD, Panagiotis Tsaftaridis, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 5193.

https://doi.org/10.1182/blood.V106.11.5193.5193

Published: 2005

Journal Articles

Serum Soluble Syndecan-1 Levels at Diagnosis Constitute an Independent Prognostic Factor of Survival in Myeloma That May Further Differentiate Patients within the ISS Stages.

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Argyro Papadogiannis, MD, Tatiana Tzenou, MD, Christina Kalpadakis, MD, Antoine Antoniadis, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Stella I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria K. Angelopoulou, MD, Ellen Plata, MD, Panagiotis Tsaftaridis, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 3404.

https://doi.org/10.1182/blood.V106.11.3404.3404

Published: 2005

Journal Articles

Topoisomerase IIα (TopoIIα) Expression in Hodgkin’s Lymphoma (HL): Correlations with Conventional and Biological Markers and Prognostic Significance under Treatment with ABVD or Equivalent Regimens with or without Radiotherapy (RT).

Theodoros P. Vassilakopoulos, MD, Ipatia A. Doussis-Anagnostopoulou, MD, Despina Karandrea, Penelope Korkolopoulou, MD, Maria K. Angelopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria N. Dimopoulou, MD, Christina Kalpadaki, MD, Maria-Christina Kyrtsonis, MD, Irini Thymara, MD, Nikolaos Kavantzas, MD, Panayiotis Panayiotidis, MD, Efstratios Patsouris, MD, Christos Kittas, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 967.

https://doi.org/10.1182/blood.V106.11.967.967

Published: 2005

Journal Articles

Excellent Outcome with Rituximab-CHOP (R-CHOP) Combined with Radiotherapy (RT) in Primary Mediastinal Large B-Cell Lymhoma (PMLBCL).

Theodoros P. Vassilakopoulos, MD, Maria K. Angelopoulou, MD, Zacharoula Galani, MD, Sotirios Sachanas, MD, Andreas Katsigiannis, MD, Maria N. Dimopoulou, MD, Styliani I. Kokoris, MD, Evridiki Michalis, MD, Evangelia M. Dimitriadou, MD, Marina P. Siakantaris, MD, Flora N. Kontopidou, MD, Christina Kalpadakis, MD, Angelos Sarantopoulos, MD, Pinelopi Korkolopoulou, MD, Paraskevi Roussou, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 935.

https://doi.org/10.1182/blood.V106.11.935.935

Published: 2005

Journal Articles

Rituximab Monotherapy Is an Effective Treatment for Splenic Marginal Zone B-Cell Lymphomas (SMZL).

Maria N. Dimopoulou, MD, Christina Kalpadakis, MD, Evangelia M. Dimitriadou, MD, Marie-Christine Kyrtsonis, MD, Styliani I. Kokoris, MD, Panagiotis Tsaftaridis, MD, Flora N. Kontopidou, MD, Marina P. Siakantaris, MD, Eleni Plata, MD, Theodoros P. Vassilakopoulos, MD, Maria K. Angelopoulou, MD, Gerassimos A. Pangalis, MD.

Blood (2005) 106 (11): 4800.

https://doi.org/10.1182/blood.V106.11.4800.4800

Published: 2005

Journal Articles

Complex Paterns of Monoclonal Ig Diversification in B-CLL Cells from Different Tissue Compartments.

Evangelia M. Dimitriadou, MD, Panayiotis Panayiotidis, MD, Vasiliki Karali, MD, Konstantinos Lilakos, PhD, Maria K. Angelopoulou, MD, Marina P. Siakantaris, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 5021.

https://doi.org/10.1182/blood.V106.11.5021.5021

Published: 2005

Journal Articles

Molecular Analysis of the VH Gene Usage in a Familial Case of Waldenstrom’s Macroglobulinemia.

Marina P. Siakantaris, MD, Marie-Christine Kyrtsonis, MD, Konstantinos Lilakos, Maria K. Angelopoulou, MD, S. Vavourakis, MD, Flora N. Kontopidou, MD, Theodoros P. Vassilakopoulos, MD, Christina Kalpadakis, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Constantin Kilindireas, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 1005.

https://doi.org/10.1182/blood.V106.11.1005.1005

Published: 2005

Journal Articles

Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma

Blood (2005) 105 (5): 1875–1880.

https://doi.org/10.1182/blood-2004-01-0379

Published: 2005

Journal Articles

Interferon Alpha-2B (IFN-a) Is an Effective Agent for the Treatment of Primary Cutaneous T- and B-Cell Lymphoma.

Marina P. Siakantaris, MD, Marie-Christine Kyrtsonis, MD, Tatiana Tzenou, MD, Evangelia M. Dimitriadou, MD, Maria N. Dimopoulou, MD, Maria K. Angelopoulou, MD, Styliani I. Kokoris, MD, Theodoros P. Vassilakopoulos, MD, Penelope Korkolopoulou, MD, Antonia Giannakakis, MD, Eleni Plata, MD, Eustratios Patsouris, MD, Andreas Katsambas, MD, Gerassimos A. Pangalis, MD

Blood (2004) 104 (11): 2643.

https://doi.org/10.1182/blood.V104.11.2643.2643

Published: 2004

NARROW

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Serum Free Light Chain Ratio (FLCR) at Diagnosis Constitute a Powerful Prognostic Factor of Survival in Multiple Myeloma (MM).

B-Chronic Lymphoproliferative Disorders (BCLD) Presenting with Splenomegaly: Differential Diagnosis and Outcome.

Long Term Follow up of Hairy Cell Leukemia (HCL) Patients (PTS) Treated with Interferon-Alpha (IFN-α). The Importance of Maintenance.

Efficacy of Rituximab in Hairy Cell Leukemia.

Rituximab-CHOP (R-CHOP) and Radiotherapy (RT) for Primary Mediastinal Large B-Cell Lymphoma (PMLBCL).

Retrospective Analysis of 41 Consecutive Patients with Non Gastrointestinal (GI) Extranodal Marginal Zone B-Cell Lymphoma (EMZL): Correlation of Clinical Characteristics and Outcome with Disease Localization.

Serum Levels of OPG and MIP-1α in Untreated Multiple Myeloma Patients. Correlations with Staging, Survival and Bone Disease.

Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.

Serum Soluble Syndecan-1 Levels at Diagnosis Constitute an Independent Prognostic Factor of Survival in Myeloma That May Further Differentiate Patients within the ISS Stages.

Topoisomerase IIα (TopoIIα) Expression in Hodgkin’s Lymphoma (HL): Correlations with Conventional and Biological Markers and Prognostic Significance under Treatment with ABVD or Equivalent Regimens with or without Radiotherapy (RT).

Excellent Outcome with Rituximab-CHOP (R-CHOP) Combined with Radiotherapy (RT) in Primary Mediastinal Large B-Cell Lymhoma (PMLBCL).

Rituximab Monotherapy Is an Effective Treatment for Splenic Marginal Zone B-Cell Lymphomas (SMZL).

Complex Paterns of Monoclonal Ig Diversification in B-CLL Cells from Different Tissue Compartments.

Molecular Analysis of the VH Gene Usage in a Familial Case of Waldenstrom’s Macroglobulinemia.

Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma

Interferon Alpha-2B (IFN-a) Is an Effective Agent for the Treatment of Primary Cutaneous T- and B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only